Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $28.6100 (0.92%) ($27.9800 - $28.6700) on Tue. Aug. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.38% (three month average) | RSI | 46 | Latest Price | $28.6100(0.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.1% a day on average for past five trading days. | Weekly Trend | HALO declines -1.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(49%) IWM(47%) IWC(45%) ARKG(42%) | Factors Impacting HALO price | HALO will decline at least -1.19% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-2%) IYT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.19% (StdDev 2.38%) | Hourly BBV | 0 () | Intraday Trend | 1% | | | |
|
5 Day Moving Average | $27.66(3.43%) | 10 Day Moving Average | $27.58(3.73%) | 20 Day Moving Average | $27.92(2.47%) | To recent high | -1.5% | To recent low | 25.4% | Market Cap | $3.91b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |